Mrs. Shelley Dostie, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Westford Dr, Ashford, CT 06278 Phone: 860-429-2646 |
Matthew Kenney, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 391 Squaw Hollow Rd, Ashford, CT 06278 Phone: 860-729-7335 |
Ryan Boisjolie, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 652 W Avon Rd, Avon, CT 06001 Phone: 860-673-2521 |
Kristen Sutton, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-2190 |
Brittney Nicole Oboikovitz-tasto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Oak Ridge Dr, Avon, CT 06001 Phone: 860-790-0116 |
Rachel Ryznic-matteson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 220 Scoville Rd, Avon, CT 06001 Phone: 860-673-3265 Fax: 860-675-3461 |
Mr. David Mark Santoro, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Chepachet Rd, Avon, CT 06001 Phone: 860-751-4040 Fax: 860-404-1811 |
Kathryn A Seifert, MOTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 136 Simsbury Rd, Building 12, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-2190 |
Alissa Gandiaga Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 652 W Avon Rd, Avon, CT 06001 Phone: 860-673-2521 |
Marilyn Sharpe, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 652 W Avon Rd, Avon, CT 06001 Phone: 860-673-2521 |
Ms. Kristen Joseph Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 652 W Avon Rd, Avon, CT 06001 Phone: 860-673-2521 |
Agnieszka Seraphin Occupational Therapist Medicare: Medicare Enrolled Practice Location: 652 W Avon Rd, Avon, CT 06001 Phone: 860-673-2521 |
Lauren Coughlin, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 49 W Main St, Avon, CT 06001 Phone: 860-284-9779 |
Mrs. Christine Marie Ross, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-677-2934 |
Mariana Angela Kriss, OTR-L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Wateville Rd, Avon, CT 06001 Phone: 860-677-2934 Fax: 860-938-2867 |
Sarah Cebry Bengtson Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 |
Colleen Anne Collins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 220 Scoville Rd, Avon, CT 06001 Phone: 860-573-6230 |
Jessica Tuthill, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 W Main St, Avon, CT 06001 Phone: 860-284-9779 |
Miss Nancy C Jackson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Allstar, Avon, CT 06001 Phone: 860-678-9755 |
Miss Jennifer Decoteau Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Bickford Ext, Avon, CT 06001 Phone: 860-269-5078 |
News Archive
A five-year, $2.59 million grant from the National Institutes of Health will allow a psychology professor at Binghamton University, State University of New York to study the mechanisms of addiction.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.
Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations.
› Verified 3 days ago